Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Genetic Associations and Epidemiology, BRCA gene mutations in cancer, Prostate Cancer Treatment and Research, and Prostate Cancer Diagnosis and Treatment.
Lifestyle characteristics and plasma biomarkers for risk of MASLD differ by sex in the general population.
VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction.
From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Prostate cancer risk stratification improved across multiple ancestries with new polygenic hazard score
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Association of<i>LPA</i>Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity
Body mass index and breast cancer survival: a Mendelian randomization analysis
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS
A genomic approach to therapeutic target validation identifies a glucose-lowering <i>GLP1R</i> variant protective for coronary heart disease